George Teeling Smith

• ABPI
• Sustainability

Supporting the Era of Green Pharmaceuticals in the UK

Read more

• Health Policy and Regulation
• Innovation
• PhRMA
• Policy Analysis
• Pricing and Reimbursement
• US
• Drug Development/R&D

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Read more

• Health Policy and Regulation
• Innovation
• PhRMA
• Policy Analysis
• US

The Lower Drug Costs Now Act and Pharmaceutical Innovation

Read more

• Health Economics

Science in Medicine: How Far Has It Advanced?

Read more

• Competition
• Innovation

Innovative Competition in Medicine

Read more